Practically speaking, however,
it seems that the production of transferable information regarding the impact of individual treatments, the
possession of comparative information regarding the effectiveness of individual technologies, will be significantly
less useful in driving an individual HTA processes, like
the French approach, than is currently imagined in the
academic literature.